BioSpace News Archive

Cyxone announced today that the first phase of their cyclotide pilot study into inflammatory bowel disease (IBD) has been concluded as planned.

Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today announced the appointment of Scott R. Sanders as Director of Clinical Education and Market Development.

Thanks to high-performance thermoplastic resin and ABS-M30i biocompatible 3D printing material, UPSA is now able to replace metal parts in some applications and reverse engineer components for part replacement; Creation of lightweight 3D printed parts decreases part weight by 70 percent, which reduces machine wear-and-tear, in turn extending productivity and machine longevity

New unit expands OHG’s footprint in world’s second largest pharmaceutical market; Takao Ozawa to lead as Managing Director

Accelovance Inc. announced that it has signed a merger agreement with Linical, a leading CRO based in Asia in the fields of oncology, immunology, and neurology.

Constant Pharmaceuticals, LLC announced that the European Patent Office (EPO) has notified the company that it will grant a patent covering the use of TXA127 in the treatment of stroke.

Mylan N.V. and Biocon Ltd. announced that their co-developed biosimilar insulin glargine Semglee™ has received marketing authorization approval from the European Commission (EC).

New full face mask brings the benefits of DreamWear CPAP mask system to broader patient population with more freedom of choice and increased flexibility

BioIVT now offers unique and proprietary bioengineered micro-liver platforms for use in environmental testing, preventive care, and product development in the pharmaceutical and biopharmaceutical, diagnostic, cosmetics, and chemical industries

Beacon Point seeks 150 individuals for positions in Port Richmond location